Dr. Jose Manuel Cervera Grau has been a practicing Clinical Oncologist for 17 years, holding an MD in the field. He is also pursuing a PhD in Biophysics, with a focus on the mathematical expression of cancer images. Since 2012, Dr. Cervera Grau has been engaged in preclinical research on advanced therapy medicinal products (ATMPs). In 2013, after completing the Advanced Certificate for Executives in Biotechnology from MIT, he joined Eli Lilly as a consultant, contributing to the clinical development of their portfolio. He later rose to the position of Executive Director, a role he held until 2024. After earning an MIT Executive Certificate in AI for Healthcare and mastering AI at Murcia University, he serves as an Executive Director in Clinical Oncology.
Dr. Jose research focuses on the application of Blockchain and Machine Learning technologies to improve efficiency in clinical trials